The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73. (Q39861969)
Jump to navigation
Jump to search
scientific article published on May 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73. |
scientific article published on May 2009 |
Statements
1 reference
The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73. (English)
1 reference
Susan K Peirce
1 reference
Harry W Findley
1 reference
1 May 2009
1 reference
1 reference